Imprivata Agrees to Be Acquired by Thoma Bravo

Go back to Imprivata Agrees to Be Acquired by Thoma Bravo

Leerink Partners Downgrades Imprivata (IMPR) to Market Perform; Doesn't See Cerner (CERN) Making Competing Bid

July 13, 2016 5:33 PM EDT

Leerink Partners downgraded Imprivata (NYSE: IMPR) from Outperform to Market Perform after the company agreed to be acquired by Thoma Bravo for $19.25/share.

Analyst David Larsen commented, "While Cerner (NASDAQ: CERN) (OP) could... More

Stifel Downgrades Imprivata (IMPR) to Hold

July 13, 2016 1:58 PM EDT

Stifel downgraded Imprivata (NYSE: IMPR) from Buy to Hold and removed its price target (prior $20.00).

For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.

Shares of Imprivata closed at $14.50 yesterday.

... More

Piper Jaffray Downgrades Imprivata (IMPR) to Neutral

July 13, 2016 12:51 PM EDT

Piper Jaffray downgraded Imprivata (NYSE: IMPR) from Overweight to Neutral.

For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.

Shares of Imprivata closed at $14.50 yesterday.

... More